S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
How to profit from the new boom in gold (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Obama’s 2024 Confession (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
How to profit from the new boom in gold (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
How to profit from the new boom in gold (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Obama’s 2024 Confession (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
How to profit from the new boom in gold (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
How to profit from the new boom in gold (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Obama’s 2024 Confession (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
How to profit from the new boom in gold (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
How to profit from the new boom in gold (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Obama’s 2024 Confession (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
How to profit from the new boom in gold (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?

Lifesci Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Lifesci Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Lifesci Capital.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$11.50
-2.0%
2/20/2024Reiterated byLifesci CapitalAnalyst C. JubinvilleOutperformLowView details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 2/20/2024
CymaBay Therapeutics, Inc. stock logo
CBAY
CymaBay Therapeutics
$32.27
-0.2%
2/14/2024Downgraded byLifesci CapitalAnalyst C. JubinvilleOutperform -> Market PerformLowView details for Lifesci Capital rating of CymaBay Therapeutics (NASDAQ:CBAY) on 2/14/2024
Inhibrx, Inc. stock logo
INBX
Inhibrx
$37.00
-6.5%
1/23/2024Downgraded byLifesci CapitalAnalyst S. SlutskyOutperform -> Market PerformLowView details for Lifesci Capital rating of Inhibrx (NASDAQ:INBX) on 1/23/2024
Inventiva S.A. stock logo
IVA
Inventiva
$3.57
-2.2%
1/5/2024Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformLowView details for Lifesci Capital rating of Inventiva (NASDAQ:IVA) on 1/5/2024
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
$37.87
-3.4%
12/26/2023Reiterated byLifesci CapitalAnalyst C. JubinvilleOutperformLowView details for Lifesci Capital rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 12/26/2023
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$29.03
-5.6%
12/26/2023Reiterated byLifesci CapitalAnalyst C. JubinvilleOutperformLowView details for Lifesci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/26/2023
CymaBay Therapeutics, Inc. stock logo
CBAY
CymaBay Therapeutics
$32.27
-0.2%
12/26/2023Reiterated byLifesci CapitalAnalyst C. JubinvilleOutperformLowView details for Lifesci Capital rating of CymaBay Therapeutics (NASDAQ:CBAY) on 12/26/2023
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$26.10
+4.8%
12/4/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/4/2023
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
$6.71
+4.0%
11/27/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of TScan Therapeutics (NASDAQ:TCRX) on 11/27/2023
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
$7.77
+28.4%
11/7/2023Downgraded byLifesci CapitalAnalyst S. SlutskyOutperform -> Market PerformLowView details for Lifesci Capital rating of Ventyx Biosciences (NASDAQ:VTYX) on 11/7/2023
Verve Therapeutics, Inc. stock logo
VERV
Verve Therapeutics
$17.96
+2.4%
8/8/2023Reiterated byLifesci CapitalAnalyst C. JubinvilleOutperformLowView details for Lifesci Capital rating of Verve Therapeutics (NASDAQ:VERV) on 8/8/2023
Inhibrx, Inc. stock logo
INBX
Inhibrx
$37.00
-6.5%
8/8/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Inhibrx (NASDAQ:INBX) on 8/8/2023
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$5.90
+1.0%
8/8/2023Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 8/8/2023
Rain Oncology Inc. stock logo
RAIN
Rain Oncology
$1.21
5/22/2023Downgraded byLifesci CapitalAnalyst S. SlutskyOutperform -> Market PerformLowView details for Lifesci Capital rating of Rain Oncology (NASDAQ:RAIN) on 5/22/2023
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$6.36
-0.2%
4/26/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Pyxis Oncology (NASDAQ:PYXS) on 4/26/2023
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
$12.97
-5.5%
4/26/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 4/26/2023
Inhibrx, Inc. stock logo
INBX
Inhibrx
$37.00
-6.5%
4/26/2023Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Inhibrx (NASDAQ:INBX) on 4/26/2023
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$12.55
-5.7%
4/26/2023Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 4/26/2023
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
$14.51
-11.6%
4/26/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 4/26/2023
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$65.14
-1.7%
4/24/2023Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformLowView details for Lifesci Capital rating of Disc Medicine (NASDAQ:IRON) on 4/24/2023
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$27.23
-0.3%
4/11/2023Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Akero Therapeutics (NASDAQ:AKRO) on 4/11/2023
InflaRx stock logo
IFRX
InflaRx
$1.74
+5.5%
4/5/2023Upgraded byLifesci Capital-Market Perform -> OutperformLowView details for Lifesci Capital rating of InflaRx (NASDAQ:IFRX) on 4/5/2023
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
$42.76
+5.7%
3/27/2023Reiterated byLifesci CapitalAnalyst C. JubinvilleOutperformLowView details for Lifesci Capital rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/27/2023
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$6.34
3/8/2023Reiterated byLifesci CapitalAnalyst R. RakhitOutperformLowView details for Lifesci Capital rating of Orchestra BioMed (NASDAQ:OBIO) on 3/8/2023
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$17.00
-3.8%
3/7/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Enliven Therapeutics (NASDAQ:ELVN) on 3/7/2023
Rain Oncology Inc. stock logo
RAIN
Rain Oncology
$1.21
1/6/2023Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Rain Oncology (NASDAQ:RAIN) on 1/6/2023
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
$56.81
+3.7%
12/21/2022Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformN/AView details for Lifesci Capital rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 12/21/2022
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$6.36
-0.2%
12/1/2022Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLowView details for Lifesci Capital rating of Pyxis Oncology (NASDAQ:PYXS) on 12/1/2022
Astria Therapeutics, Inc. stock logo
ATXS
Astria Therapeutics
$14.93
+6.8%
11/28/2022Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Astria Therapeutics (NASDAQ:ATXS) on 11/28/2022
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
$14.51
-11.6%
11/8/2022Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLowView details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 11/8/2022
Akili, Inc. stock logo
AKLI
Akili
$0.42
-10.7%
9/6/2022Reiterated byLifesci CapitalAnalyst R. RakhitOutperformLowView details for Lifesci Capital rating of Akili (NASDAQ:AKLI) on 9/6/2022
VYNE Therapeutics Inc. stock logo
VYNE
VYNE Therapeutics
$2.33
-1.7%
8/12/2022Downgraded byLifesci CapitalAnalyst P. DolezalOutperform -> Market PerformLowView details for Lifesci Capital rating of VYNE Therapeutics (NASDAQ:VYNE) on 8/12/2022
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$11.50
-2.0%
8/12/2022Upgraded byLifesci CapitalAnalyst P. DolezalMarket Perform -> OutperformLowView details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 8/12/2022
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$5.90
+1.0%
6/16/2022Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Tenaya Therapeutics (NASDAQ:TNYA) on 6/16/2022
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$45.94
-4.6%
3/28/2022Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformLowView details for Lifesci Capital rating of Vera Therapeutics (NASDAQ:VERA) on 3/28/2022
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
$1.84
+0.5%
3/25/2022Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformMediumView details for Lifesci Capital rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/25/2022
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$11.50
-2.0%
2/16/2022Downgraded byLifesci CapitalAnalyst Patrick DolezalOutperform -> Market Perform$3.00MediumView details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 2/16/2022
Verve Therapeutics, Inc. stock logo
VERV
Verve Therapeutics
$17.96
+2.4%
12/22/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformHighView details for Lifesci Capital rating of Verve Therapeutics (NASDAQ:VERV) on 12/22/2021
Allakos Inc. stock logo
ALLK
Allakos
$1.55
-3.1%
12/22/2021Downgraded byLifesci CapitalAnalyst S. SlutskyOutperform -> Market PerformHighView details for Lifesci Capital rating of Allakos (NASDAQ:ALLK) on 12/22/2021
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$11.83
+1.9%
11/17/2021Downgraded byLifesci CapitalAnalyst R. RakhitOutperform -> Market PerformLowView details for Lifesci Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 11/17/2021
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
$7.77
+28.4%
11/15/2021Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHighView details for Lifesci Capital rating of Ventyx Biosciences (NASDAQ:VTYX) on 11/15/2021
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
$14.51
-11.6%
11/4/2021Reiterated byLifesci CapitalAnalyst A. EverttsOutperformMediumView details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 11/4/2021
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$6.36
-0.2%
11/2/2021Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLowView details for Lifesci Capital rating of Pyxis Oncology (NASDAQ:PYXS) on 11/2/2021
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$29.03
-5.6%
10/24/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/24/2021
DarioHealth Corp. stock logo
DRIO
DarioHealth
$2.21
+2.8%
8/26/2021Reiterated byLifesci CapitalAnalyst R. RakhitOutperformHighView details for Lifesci Capital rating of DarioHealth (NASDAQ:DRIO) on 8/26/2021
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$20.17
+2.9%
8/24/2021Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformLowView details for Lifesci Capital rating of Viridian Therapeutics (NASDAQ:VRDN) on 8/24/2021
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$11.50
-2.0%
8/4/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMediumView details for Lifesci Capital rating of Larimar Therapeutics (NASDAQ:LRMR) on 8/4/2021
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
$12.97
-5.5%
6/21/2021Reiterated byLifesci CapitalAnalyst A. EverttsOutperformHighView details for Lifesci Capital rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 6/21/2021
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$11.83
+1.9%
6/3/2021Reiterated byLifesci CapitalAnalyst R. RakhitOutperformHighView details for Lifesci Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 6/3/2021
VectivBio Holding AG stock logo
VECT
VectivBio
$16.85
5/4/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformHighView details for Lifesci Capital rating of VectivBio (NASDAQ:VECT) on 5/4/2021
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
$1.97
-1.5%
4/29/2021Downgraded byLifesci CapitalAnalyst P. DolezalOutperform -> Market PerformHighView details for Lifesci Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/29/2021
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
$1.84
+0.5%
3/18/2021Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformHighView details for Lifesci Capital rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/18/2021
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$7.34
-2.0%
1/4/2021Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformN/AView details for Lifesci Capital rating of Cogent Biosciences (NASDAQ:COGT) on 1/4/2021
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$51.37
+0.6%
11/17/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHighView details for Lifesci Capital rating of Celldex Therapeutics (NASDAQ:CLDX) on 11/17/2020
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
$37.87
-3.4%
11/10/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMediumView details for Lifesci Capital rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 11/10/2020
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
$12.55
-5.7%
11/9/2020Reiterated byLifesci CapitalAnalyst D. ShermanOutperformLowView details for Lifesci Capital rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 11/9/2020
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
$1.97
-1.5%
11/5/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMediumView details for Lifesci Capital rating of Adverum Biotechnologies (NASDAQ:ADVM) on 11/5/2020
InflaRx stock logo
IFRX
InflaRx
$1.74
+5.5%
10/30/2020Reiterated byLifesci CapitalAnalyst S. SlutskyMarket PerformLowView details for Lifesci Capital rating of InflaRx (NASDAQ:IFRX) on 10/30/2020
Allakos Inc. stock logo
ALLK
Allakos
$1.55
-3.1%
10/22/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLowView details for Lifesci Capital rating of Allakos (NASDAQ:ALLK) on 10/22/2020
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
$4.18
10/21/2020Reiterated byLifesci CapitalAnalyst A. EverttsOutperformMediumView details for Lifesci Capital rating of MEI Pharma (NASDAQ:MEIP) on 10/21/2020
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$29.03
-5.6%
10/16/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLowView details for Lifesci Capital rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/16/2020
Inhibrx, Inc. stock logo
INBX
Inhibrx
$37.00
-6.5%
10/15/2020Reiterated byLifesci CapitalAnalyst A. EverttsOutperformMediumView details for Lifesci Capital rating of Inhibrx (NASDAQ:INBX) on 10/15/2020
Immunovant, Inc. stock logo
IMVT
Immunovant
$37.66
-1.8%
10/6/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHighView details for Lifesci Capital rating of Immunovant (NASDAQ:IMVT) on 10/6/2020
VYNE Therapeutics Inc. stock logo
VYNE
VYNE Therapeutics
$2.33
-1.7%
10/2/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformHighView details for Lifesci Capital rating of VYNE Therapeutics (NASDAQ:VYNE) on 10/2/2020
CymaBay Therapeutics, Inc. stock logo
CBAY
CymaBay Therapeutics
$32.27
-0.2%
9/29/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMediumView details for Lifesci Capital rating of CymaBay Therapeutics (NASDAQ:CBAY) on 9/29/2020
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
$14.51
-11.6%
9/30/2020Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLowView details for Lifesci Capital rating of ALX Oncology (NASDAQ:ALXO) on 9/30/2020
Cortexyme, Inc. stock logo
CRTX
Cortexyme
$1.34
+1.5%
9/24/2020Reiterated byLifesci CapitalAnalyst D. ShermanOutperformHighView details for Lifesci Capital rating of Cortexyme (NASDAQ:CRTX) on 9/24/2020

MarketBeat Community Rating for Lifesci Capital

Community Ranking:  2.4 out of 5 (
2.4 of 5 stars)
Outperform Votes:  5,455 (Vote Outperform)
Underperform Votes:  5,770 (Vote Underperform)
Total Votes:  11,225
MarketBeat's community ratings are surveys of what our community members think about Lifesci Capital and other research firms. Vote "Outperform" if you believe Lifesci Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Lifesci Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools